Search

Novocure Ltd

Geschlossen

BrancheGesundheitswesen

17.85 1.83

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

17.78

Max

18.01

Schlüsselkennzahlen

By Trading Economics

Einkommen

55M

-16M

Verkäufe

9.5M

184M

EPS

-0.13

Gewinnspanne

-8.529

Angestellte

1,605

EBITDA

53M

-11M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+64.44% upside

Dividenden

By Acuity

Nächstes Ergebnis

29. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

209M

2.1B

Vorheriger Eröffnungskurs

16.02

Vorheriger Schlusskurs

17.85

Nachrichtenstimmung

By Acuity

55%

45%

254 / 339 Ranking in Healthcare

Novocure Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Sept. 2026, 20:08 UTC

News

Novocure Ltd is trading higher as it prepares for two investor events, including chats at the Wells Fargo and Morgan Stanley healthcare conferences.

1. Sept. 2026, 19:11 UTC

News

Novocure Ltd shares are lower following a data breach affecting over 1,400 U.S. records, disclosed in a regulatory filing earlier today.

28. Aug. 2026, 20:07 UTC

Novocure Ltd. shares are lower today, pulled back from earlier gains amid rising U.S. Treasury yields impacting broader equity markets.

27. Aug. 2026, 22:01 UTC

Novocure Ltd. shares are lower in after-market hours, reversing a three-session upward trend and moving below the 20-day moving average.

26. Aug. 2026, 20:08 UTC

Novocure Ltd's shares are higher today, continuing an upward trend. The stock is trading above its 20-day moving average and near its one-month range high.

25. Aug. 2026, 20:07 UTC

Novocure Ltd shares are higher today, reversing three days of declines. Easing Treasury yields and lower oil prices have supported overall market sentiment.

24. Aug. 2026, 21:01 UTC

Novocure Ltd. shares are higher in after-market hours, continuing a positive move since Monday's close and trading above the 20-day moving average.

21. Aug. 2026, 23:41 UTC

In after-market trading, Novocure Ltd shares moved higher, reaching the upper end of their one-month trading range, 5.40% above the 20-day moving average.

20. Aug. 2026, 19:16 UTC

Novocure shares are lower today, having reached a session low earlier. No specific company news was identified to explain the decline.

19. Aug. 2026, 23:11 UTC

Novocure Ltd shares closed higher in after-market trading, recovering from earlier lows and finishing above their 20-day moving average. No specific news was identified.

17. Aug. 2026, 19:56 UTC

Novocure Ltd. shares are trading higher, rebounding from recent declines and remaining above the 20-day moving average, indicating a shift in momentum.

15. Aug. 2026, 00:01 UTC

Novocure Ltd. shares are higher in after-market trading, showing notable strength since Friday's close and currently above the 20-day moving average.

14. Aug. 2026, 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

13. Aug. 2026, 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

12. Aug. 2026, 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

11. Aug. 2026, 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

10. Aug. 2026, 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

8. Aug. 2026, 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

7. Aug. 2026, 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

6. Aug. 2026, 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

5. Aug. 2026, 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

4. Aug. 2026, 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

3. Aug. 2026, 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

31. Juli 2026, 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

30. Juli 2026, 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

29. Juli 2026, 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

28. Juli 2026, 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

27. Juli 2026, 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

24. Juli 2026, 19:41 UTC

News
Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

22. Juli 2026, 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

Peer-Vergleich

Kursveränderung

Novocure Ltd Prognose

Kursziel

By TipRanks

64.44% Vorteil

12-Monats-Prognose

Durchschnitt 29.5 USD  64.44%

Hoch 52 USD

Tief 17 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Novocure Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Stimmung

By Acuity

254 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat